Naya Biosciences, Stock Performance
| NAYA Stock | 0.20 0.01 4.76% |
The firm secures a Beta (Market Risk) of -1.03, which conveys a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning NAYA Biosciences, are expected to decrease slowly. On the other hand, during market turmoil, NAYA Biosciences, is expected to outperform it slightly. At this point, NAYA Biosciences, has a negative expected return of -1.85%. Please make sure to verify NAYA Biosciences,'s potential upside, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if NAYA Biosciences, performance from the past will be repeated at future time.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days NAYA Biosciences, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Last Split Factor 1:20 | Dividend Date 2020-11-09 | Last Split Date 2023-07-28 |
1 | NAYA Biosciences Announces Development of NY-500,a Novel AI-Opt | 01/06/2025 |
2 | NAYA Biosciences Announces Pricing of 9.5 Million Public Offeri | 01/13/2025 |
3 | Can These 5 Biotech Powerhouses Transform NAYAs Future Meet the New Board Nominees - StockTitan | 02/19/2025 |
4 | NAYA Announces a 112 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025 | 03/13/2025 |
| Begin Period Cash Flow | 90.1 K |
NAYA |
NAYA Biosciences, Relative Risk vs. Return Landscape
If you would invest 80.00 in NAYA Biosciences, on December 17, 2024 and sell it today you would lose (60.00) from holding NAYA Biosciences, or give up 75.0% of portfolio value over 90 days. NAYA Biosciences, is currently does not generate positive expected returns and assumes 8.7118% risk (volatility on return distribution) over the 90 days horizon. In different words, 77% of stocks are less volatile than NAYA, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NAYA Biosciences, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NAYA Biosciences,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NAYA Biosciences,, and traders can use it to determine the average amount a NAYA Biosciences,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2121
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NAYA |
Estimated Market Risk
| 8.71 actual daily | 77 77% of assets are less volatile |
Expected Return
| -1.85 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average NAYA Biosciences, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NAYA Biosciences, by adding NAYA Biosciences, to a well-diversified portfolio.
NAYA Biosciences, Fundamentals Growth
NAYA Stock prices reflect investors' perceptions of the future prospects and financial health of NAYA Biosciences,, and NAYA Biosciences, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NAYA Stock performance.
| Current Valuation | 14.07 M | ||||
| Shares Outstanding | 4.48 M | ||||
| Price To Book | 5.97 X | ||||
| Price To Sales | 0.18 X | ||||
| Revenue | 3.02 M | ||||
| EBITDA | (6.88 M) | ||||
| Net Income | (8.03 M) | ||||
| Total Debt | 6.3 M | ||||
| Book Value Per Share | (3.91) X | ||||
| Cash Flow From Operations | (4.76 M) | ||||
| Earnings Per Share | (1.01) X | ||||
| Market Capitalization | 2.48 M | ||||
| Total Asset | 18.51 M | ||||
| Retained Earnings | (57.82 M) | ||||
| Working Capital | (6.74 M) | ||||
About NAYA Biosciences, Performance
By analyzing NAYA Biosciences,'s fundamental ratios, stakeholders can gain valuable insights into NAYA Biosciences,'s financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NAYA Biosciences, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NAYA Biosciences, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 57.39 | 54.53 | |
| Return On Tangible Assets | (0.85) | (0.89) | |
| Return On Capital Employed | (0.74) | (0.70) | |
| Return On Assets | (0.39) | (0.41) | |
| Return On Equity | (10.35) | (9.83) |
Things to note about NAYA Biosciences, performance evaluation
Checking the ongoing alerts about NAYA Biosciences, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NAYA Biosciences, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NAYA Biosciences, generated a negative expected return over the last 90 days | |
| NAYA Biosciences, has high historical volatility and very poor performance | |
| NAYA Biosciences, has some characteristics of a very speculative penny stock | |
| NAYA Biosciences, has a very high chance of going through financial distress in the upcoming years | |
| NAYA Biosciences, was previously known as INVO Old and was traded on NASDAQ Exchange under the symbol INVO. | |
| The company reported the previous year's revenue of 3.02 M. Net Loss for the year was (8.03 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NAYA Biosciences, generates negative cash flow from operations | |
| About 16.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: NAYA Announces a 112 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025 |
- Analyzing NAYA Biosciences,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NAYA Biosciences,'s stock is overvalued or undervalued compared to its peers.
- Examining NAYA Biosciences,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NAYA Biosciences,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of NAYA Biosciences,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NAYA Biosciences,'s stock. These opinions can provide insight into NAYA Biosciences,'s potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NAYA Stock analysis
When running NAYA Biosciences,'s price analysis, check to measure NAYA Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NAYA Biosciences, is operating at the current time. Most of NAYA Biosciences,'s value examination focuses on studying past and present price action to predict the probability of NAYA Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NAYA Biosciences,'s price. Additionally, you may evaluate how the addition of NAYA Biosciences, to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |